Migraine Trial, Recruiting
Who may be able to join
AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI
Who might be able to join this trial:
- People who speak English (the app used in this trial is currently only available in English)
- People aged 16 or older
- People whose headaches meet a recognised medical definition of migraine, based on information assessed during the study screening process
- People who have had headaches for at least 1 year, with a consistent pattern over the past 3 or more months
- People who are willing to avoid making any changes to their migraine prevention medications for 3 months before the trial starts and throughout the 6-week treatment part of the study
- People who experience between 4 and 29 headache days per month
- People whose quality of life is affected enough by migraine to potentially benefit from the treatment, based on a specific questionnaire score (the MSQv2 score must be below 75 for the "role restrictive" section)
Who may not be able to join:
- People who have had Cognitive Behavioural Therapy (CBT), Biofeedback, or other relaxation therapy for migraine in the past year
- People with a history of alcohol or substance misuse, identified through self-reporting or medical records
- People who have been diagnosed with medication overuse headache, or who use opioid or barbiturate medications
- People whose depression symptom score on a questionnaire (PHQ-8) is greater than 15, which indicates moderately severe depressive symptoms
- People who are unwilling or unable to follow a treatment program that uses written materials and audio recordings
- People who do not own a smartphone
- People who are pregnant
Important: Always verify eligibility with the trial site directly before applying.
Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.
Contact this trial
Principal Investigator: Mia T Minen, MD, NYU Langone Health
Phone: 212-263-7744
Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.
GP referral letter
Print a one-page summary to share with your doctor.
Trial details
Where this trial is recruiting
Primary endpoints
Change from Baseline in Modified Monthly Migraine Disability Assessment Scale (mMIDAS) Score
Can't join this trial?
Data last synced from ClinicalTrials.gov: 26 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.